Latest Trials

EudraCT Number: 2006-003255-20 Sponsor Protocol Number: CRAD001C2241 Start Date: 2006-11-23
Sponsor Name: NOVARTIS FARMA
Full Title: A single arm, multicenter phase II study of RAD001 in patients with metastatic colorectal adenocarcinoma whose cancer has progressed despite prior therapy with an anti-EGFR antibody (if appropriate...
Medical condition: metastatic colorectal adenocarcinoma
Disease: Version SOC Term Classification Code Term Level
9.1 10051925 Intestinal adenocarcinoma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe